These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7781275)

  • 1. Blood protein defects associated with thrombosis. Laboratory assessment.
    Bick RL; Ancypa D
    Clin Lab Med; 1995 Mar; 15(1):125-63. PubMed ID: 7781275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromes of hypercoagulability and thrombosis: a review.
    Bick RL; Pegram M
    Semin Thromb Hemost; 1994; 20(1):109-32. PubMed ID: 8059229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercoagulability and thrombosis.
    Bick RL
    Med Clin North Am; 1994 May; 78(3):635-65. PubMed ID: 8170263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombophilic states].
    Chrobák L; Dulícek P
    Vnitr Lek; 1998 Aug; 44(8):481-6. PubMed ID: 10358455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiphospholipid and thrombosis (APL-T) syndromes. Clinical and laboratory correlates.
    Bick RL; Ancypa D
    Clin Lab Med; 1995 Mar; 15(1):63-84. PubMed ID: 7781279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic factors in children with stroke or porencephaly.
    Lynch JK; Han CJ; Nee LE; Nelson KB
    Pediatrics; 2005 Aug; 116(2):447-53. PubMed ID: 16061602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematologic disorders and cerebral venous thrombosis.
    Akhtar N; Deleu D; Kamran S
    J Pak Med Assoc; 2006 Nov; 56(11):498-501. PubMed ID: 17183975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
    Eid SS
    Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant proteins in childhood venous and arterial thrombosis: a review.
    Segel GB; Francis CA
    Blood Cells Mol Dis; 2000 Oct; 26(5):540-60. PubMed ID: 11112387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin antibodies and thrombosis.
    Bick RL; Baker WF
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1287-99. PubMed ID: 1452512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
    Zöller B; García de Frutos P; Dahlbäck B
    Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of hemostatic risk factors in predicting arterial thrombotic events.
    Feinbloom D; Bauer KA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2043-53. PubMed ID: 16100033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.